| Followers | 129 |
| Posts | 2150 |
| Boards Moderated | 1 |
| Alias Born | 12/27/2007 |
Wednesday, August 21, 2019 3:02:23 PM
4 Drugs nearing FDA approval first one in October .....
(ETON) Market Cap $99 Million / Cash $16 Million enough until late 2020 / 4 Drugs awaiting FDA approval/ first FDA decision on October 21 / 3 NDA submission expected in Q4 2019 (more infos below) / Low float and undiscovered Stock with massive upside potential .
Potential Upcoming Business Milestones:
ET-104 Clinical Results (Third Quarter 2019)
ET-103 Clinical Results (Third Quarter 2019)
ET-202 PDUFA Date (October 21, 2019)
Potential ET-103 NDA Submission (Fourth Quarter 2019)
Potential ET-104 NDA Submission (Fourth Quarter 2019)
Potential DS-300 ANDA Submission (Fourth Quarter 2019)
EM-100 Amendment Submission (Fourth Quarter 2019)
ET-105 PDUFA Date (March 17, 2020)
Potential EM-100 FDA Response (First Quarter 2020)
(ETON) Market Cap $99 Million / Cash $16 Million enough until late 2020 / 4 Drugs awaiting FDA approval/ first FDA decision on October 21 / 3 NDA submission expected in Q4 2019 (more infos below) / Low float and undiscovered Stock with massive upside potential .
Potential Upcoming Business Milestones:
ET-104 Clinical Results (Third Quarter 2019)
ET-103 Clinical Results (Third Quarter 2019)
ET-202 PDUFA Date (October 21, 2019)
Potential ET-103 NDA Submission (Fourth Quarter 2019)
Potential ET-104 NDA Submission (Fourth Quarter 2019)
Potential DS-300 ANDA Submission (Fourth Quarter 2019)
EM-100 Amendment Submission (Fourth Quarter 2019)
ET-105 PDUFA Date (March 17, 2020)
Potential EM-100 FDA Response (First Quarter 2020)
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
